A startup with Theranos ties has another blood test in the works. This time, competition is waiting.

Diagnostics companies are having trouble escaping the shadow cast by Theranos, the blood testing biotech that failed in spectacular fashion. That challenge is already facing the new diagnostics startup Haemanthus — and it hasn’t even emerged from stealth.

Of…